(0.01%) 5 249.24 points
(0.00%) 39 759 points
(-0.13%) 16 378 points
(1.22%) $82.34
(1.22%) $1.739
(0.64%) $2 226.90
(0.06%) $24.77
(1.12%) $919.90
(0.22%) $0.925
(0.59%) $10.83
(0.01%) $0.791
(-0.40%) $92.07
@ $8.60
Issued: 14 Feb 2024 @ 15:09
Return: -25.00%
Previous signal: Feb 14 - 12:47
Previous signal:
Return: -2.05 %
Live Chart Being Loaded With Signals
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors...
Stats | |
---|---|
Today's Volume | 61 062.00 |
Average Volume | 2.23M |
Market Cap | 670.24M |
EPS | $0 ( 2024-03-12 ) |
Next earnings date | ( $-0.500 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.67 |
ATR14 | $0.0300 (0.47%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-16 | Fairmount Funds Management Llc | Buy | 1 166 666 | Common Stock |
2024-02-16 | Fairmount Funds Management Llc | Buy | 1 500 | Series B Convertible Preferred Stock |
2024-01-23 | Robinson John Edward | Buy | 300 000 | Stock Option (Right to Buy) |
2024-01-23 | Kearns Evan | Buy | 255 000 | Stock Option (Right to Buy) |
2024-01-23 | Sachs Jessica | Buy | 300 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 97 transactions |
Buy: 19 240 363 | Sell: 1 265 393 |
Volume Correlation
Cogint Inc. Correlation
10 Most Positive Correlations | |
---|---|
NWL | 0.911 |
CPIX | 0.903 |
PRAX | 0.9 |
CNDT | 0.891 |
EWTX | 0.89 |
QMCO | 0.887 |
AQB | 0.886 |
AVDX | 0.886 |
SRTS | 0.885 |
CHB | 0.885 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cogint Inc. Correlation - Currency/Commodity
Cogint Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-3.59M (0.00 %) |
EPS: | $-2.42 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-794 000 (0.00 %) |
EPS: | $-0.630 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-855 000 (0.00 %) |
EPS: | $-0.640 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.22M (0.00 %) |
EPS: | $-0.590 |
Financial Reports:
No articles found.
Cogint Inc.
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators